{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:44:45Z","timestamp":1778640285546,"version":"3.51.4"},"reference-count":42,"publisher":"Walter de Gruyter GmbH","issue":"11-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperinsulinaemic hypoglycaemia (HH) is characterised by inappropriate insulin secretion and is the most common cause for persistent neonatal hypoglycaemia. The only treatment available for medically unresponsive hypoglycaemia is a near-total pancreatectomy. A neonate with severe HH, due to a homozygous<\/jats:p>","DOI":"10.1515\/jpem-2015-0094","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T17:21:27Z","timestamp":1438276887000},"source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia"],"prefix":"10.1515","volume":"28","author":[{"given":"Mary B.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinutha B.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glynis","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin de","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Siafarikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Whan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Ellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine S.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref111","first-page":"166","article-title":"Sang Successful treatment of congenital hyperinsulinism with long - acting release octreotide","author":"Le Quan","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"ref141","first-page":"1","article-title":"General recommendations on immunization Recommendations of the Advisory Committee on Immunization Practices","author":"ACIP","year":"2011","journal-title":"Rep"},{"key":"ref301","first-page":"99","article-title":"Long - term follow up of children with congenital hyperinsulinism on octreotide therapy","author":"Demirbilek","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref71","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-013-2505-9","article-title":"mTOR inhibitors in pediatric kidney transplantation","volume":"29","author":"Pape","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/fn.82.2.F108","article-title":"Persistent hyperinsulinaemic hypoglycaemia of infancy a heterogeneous syndrome unrelated to nesidioblastosis Neonatal","volume":"12","author":"Rahier","year":"2000","journal-title":"Arch Dis Child Fetal"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/pde.12023","article-title":"JG Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome","volume":"30","author":"Kaylani","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"ref191","first-page":"168","article-title":"Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia","author":"Bernard","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"ref441","first-page":"53","article-title":"Signaling elements involved in the metabolic regulation of mTOR by nutrients incretins and growth factors in islets","author":"Kwon","year":"2004","journal-title":"Diabetes"},{"key":"ref31","first-page":"20","article-title":"CA specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism","volume":"32","author":"Palladino","year":"2011"},{"key":"ref181","first-page":"360","article-title":"Glycemic control in patients with insulinoma treated with everolimus","author":"Kulke","year":"2009","journal-title":"Engl J Med"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/fn.82.2.F108","article-title":"Persistent hyperinsulinaemic hypoglycaemia of infancy a heterogeneous syndrome unrelated to nesidioblastosis Neonatal","volume":"12","author":"Rahier","year":"2000","journal-title":"Arch Dis Child Fetal"},{"key":"ref461","first-page":"360","article-title":"Glycemic control in patients with insulinoma treated with everolimus","author":"Kulke","year":"2009","journal-title":"Engl J Med"},{"key":"ref171","first-page":"28","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy : a phase II trial","author":"Yao","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"24","author":"Hammill","year":"2011","journal-title":"AM Pediatr Blood Cancer"},{"key":"ref11","first-page":"13","article-title":"of congenital hyperinsulinemic hypoglycemia","volume":"20","author":"Flanagan","year":"2011","journal-title":"Genetics"},{"key":"ref61","first-page":"370","article-title":"Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia","author":"Senniappan","year":"2014","journal-title":"Engl J Med"},{"key":"ref341","first-page":"370","article-title":"Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia","author":"Senniappan","year":"2014","journal-title":"Engl J Med"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11523-009-0107-z","article-title":"The emerging safety profile of mTOR inhibitors a novel class of anticancer agents","author":"Sankhala","year":"2009","journal-title":"Target Oncol"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-3046.2005.00360.x","article-title":"Replacing calcineurin inhibitors with mTOR inhibitors in children","author":"Sindhi","year":"2005","journal-title":"Pediatr Transplant"},{"key":"ref51","first-page":"691","article-title":"RE Persistent hyperinsulinemic hypoglycemia of infancy : constitutive activation of the mTOR pathway with associated exocrine - islet transdifferentiation and therapeutic implications","author":"Alexandrescu","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"ref241","first-page":"140","article-title":"Kai a promising treatment for refractory Kaposiform hemangioendothelioma","author":"Wang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref521","first-page":"140","article-title":"Kai a promising treatment for refractory Kaposiform hemangioendothelioma","author":"Wang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref371","doi-asserted-by":"crossref","DOI":"10.1177\/193229681300700604","article-title":"Rack an advanced continuous glucose monitor for the artificial pancreas","author":"Garcia","year":"2013","journal-title":"Diabetes Sci Technol"},{"key":"ref471","first-page":"168","article-title":"Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia","author":"Bernard","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"ref21","first-page":"99","article-title":"Long - term follow up of children with congenital hyperinsulinism on octreotide therapy","author":"Demirbilek","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref161","first-page":"53","article-title":"Signaling elements involved in the metabolic regulation of mTOR by nutrients incretins and growth factors in islets","author":"Kwon","year":"2004","journal-title":"Diabetes"},{"key":"ref291","first-page":"13","article-title":"of congenital hyperinsulinemic hypoglycemia","volume":"20","author":"Flanagan","year":"2011","journal-title":"Genetics"},{"key":"ref91","doi-asserted-by":"crossref","DOI":"10.1177\/193229681300700604","article-title":"Rack an advanced continuous glucose monitor for the artificial pancreas","author":"Garcia","year":"2013","journal-title":"Diabetes Sci Technol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11523-009-0107-z","article-title":"The emerging safety profile of mTOR inhibitors a novel class of anticancer agents","author":"Sankhala","year":"2009","journal-title":"Target Oncol"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/db07-0922","article-title":"mTOR inhibition by rapamycin prevents beta - cell adaptation to hyperglycemia and exacerbates the metabolic state in type diabetes","author":"Fraenkel","year":"2008","journal-title":"Diabetes"},{"key":"ref331","first-page":"691","article-title":"RE Persistent hyperinsulinemic hypoglycemia of infancy : constitutive activation of the mTOR pathway with associated exocrine - islet transdifferentiation and therapeutic implications","author":"Alexandrescu","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"ref351","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-013-2505-9","article-title":"mTOR inhibitors in pediatric kidney transplantation","volume":"29","author":"Pape","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"ref451","first-page":"28","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy : a phase II trial","author":"Yao","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref391","first-page":"166","article-title":"Sang Successful treatment of congenital hyperinsulinism with long - acting release octreotide","author":"Le Quan","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-3046.2005.00360.x","article-title":"Replacing calcineurin inhibitors with mTOR inhibitors in children","author":"Sindhi","year":"2005","journal-title":"Pediatr Transplant"},{"key":"ref311","first-page":"20","article-title":"CA specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism","volume":"32","author":"Palladino","year":"2011"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"24","author":"Hammill","year":"2011","journal-title":"AM Pediatr Blood Cancer"},{"key":"ref421","first-page":"1","article-title":"General recommendations on immunization Recommendations of the Advisory Committee on Immunization Practices","author":"ACIP","year":"2011","journal-title":"Rep"},{"key":"ref121","first-page":"49","article-title":"Beta - cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy","author":"Kassem","year":"2000","journal-title":"PS Diabetes"},{"key":"ref401","first-page":"49","article-title":"Beta - cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy","author":"Kassem","year":"2000","journal-title":"PS Diabetes"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/db07-0922","article-title":"mTOR inhibition by rapamycin prevents beta - cell adaptation to hyperglycemia and exacerbates the metabolic state in type diabetes","author":"Fraenkel","year":"2008","journal-title":"Diabetes"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/pde.12023","article-title":"JG Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome","volume":"30","author":"Kaylani","year":"2013","journal-title":"Pediatr Dermatol"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2015-0094\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:39:05Z","timestamp":1619055545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2015-0094\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":42,"journal-issue":{"issue":"11-12"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2015-0094","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}